These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24381270)

  • 1. Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS.
    Yin S; Noetzel MJ; Johnson KA; Zamorano R; Jalan-Sakrikar N; Gregory KJ; Conn PJ; Niswender CM
    J Neurosci; 2014 Jan; 34(1):79-94. PubMed ID: 24381270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
    Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
    Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
    Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
    ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells.
    Moreno Delgado D; Møller TC; Ster J; Giraldo J; Maurel D; Rovira X; Scholler P; Zwier JM; Perroy J; Durroux T; Trinquet E; Prezeau L; Rondard P; Pin JP
    Elife; 2017 Jun; 6():. PubMed ID: 28661401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional selectivity induced by mGlu₄ receptor positive allosteric modulation and concomitant activation of Gq coupled receptors.
    Yin S; Zamorano R; Conn PJ; Niswender CM
    Neuropharmacology; 2013 Mar; 66():122-32. PubMed ID: 22426233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a novel metabotropic glutamate receptor 7 negative allosteric modulator, 6-(4-methoxyphenyl)-5-methyl-3-pyridin-4-ylisoxazonolo[4,5-c]pyridin-4(5H)-one (MMPIP), on the central nervous system in rodents.
    Hikichi H; Murai T; Okuda S; Maehara S; Satow A; Ise S; Nishino M; Suzuki G; Takehana H; Hata M; Ohta H
    Eur J Pharmacol; 2010 Aug; 639(1-3):106-14. PubMed ID: 20371227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders.
    Spooren WP; Gasparini F; Salt TE; Kuhn R
    Trends Pharmacol Sci; 2001 Jul; 22(7):331-7. PubMed ID: 11431019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are compounds acting at metabotropic glutamate receptors the answer to treating depression?
    Palucha A
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1545-53. PubMed ID: 17107280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurobiological Insights from mGlu Receptor Allosteric Modulation.
    O'Brien DE; Conn PJ
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26647381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
    Bennouar KE; Uberti MA; Melon C; Bacolod MD; Jimenez HN; Cajina M; Kerkerian-Le Goff L; Doller D; Gubellini P
    Neuropharmacology; 2013 Mar; 66():158-69. PubMed ID: 22491024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.
    Sheffler DJ; Pinkerton AB; Dahl R; Markou A; Cosford ND
    ACS Chem Neurosci; 2011 Aug; 2(8):382-93. PubMed ID: 22860167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist.
    Schoepp DD; Johnson BG; Wright RA; Salhoff CR; Monn JA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):175-80. PubMed ID: 9750002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.
    Noetzel MJ; Rook JM; Vinson PN; Cho HP; Days E; Zhou Y; Rodriguez AL; Lavreysen H; Stauffer SR; Niswender CM; Xiang Z; Daniels JS; Jones CK; Lindsley CW; Weaver CD; Conn PJ
    Mol Pharmacol; 2012 Feb; 81(2):120-33. PubMed ID: 22021324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator.
    Rosenbrock H; Kramer G; Hobson S; Koros E; Grundl M; Grauert M; Reymann KG; Schröder UH
    Eur J Pharmacol; 2010 Aug; 639(1-3):40-6. PubMed ID: 20371241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer.
    Liu J; Zhang Z; Moreno-Delgado D; Dalton JA; Rovira X; Trapero A; Goudet C; Llebaria A; Giraldo J; Yuan Q; Rondard P; Huang S; Liu J; Pin JP
    Elife; 2017 Aug; 6():. PubMed ID: 28829739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential.
    Goudet C; Vilar B; Courtiol T; Deltheil T; Bessiron T; Brabet I; Oueslati N; Rigault D; Bertrand HO; McLean H; Daniel H; Amalric M; Acher F; Pin JP
    FASEB J; 2012 Apr; 26(4):1682-93. PubMed ID: 22223752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computationally Guided Identification of Allosteric Agonists of the Metabotropic Glutamate 7 Receptor.
    Cid JM; Lavreysen H; Tresadern G; Pérez-Benito L; Tovar F; Fontana A; Trabanco AA
    ACS Chem Neurosci; 2019 Mar; 10(3):1043-1054. PubMed ID: 30216043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic frontiers for metabotropic glutamate receptors.
    Niswender CM; Jones CK; Conn PJ
    Curr Top Med Chem; 2005; 5(9):847-57. PubMed ID: 16178730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.